Targeting Antigen‐Presenting Cells to Enhance the Tumor‐Spleen Immunity Cycle through Liposome‐Neoantigen Vaccine
Abstract Effective immune responses in both the spleen and the tumor microenvironment are crucial for cancer immunotherapy. However, delivery of neoantigen peptide vaccines to antigen‐presenting cells (APCs) at these sites remains challenging. In this study, LNPsD18, a cationic liposomal formulation...
Saved in:
| Main Authors: | Yu Xu, Bing Wang, Yue Huang, JianPing Liao, Chenyi Wu, Chenxi Zhou, Zishi Kang, Shiyang Jiang, Bing‐Chen Wu, Da Zhang, Ruihua Xu, Xiaolong Liu, Feng Wang |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2025-05-01
|
| Series: | Advanced Science |
| Subjects: | |
| Online Access: | https://doi.org/10.1002/advs.202500021 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Relevance of mutation-derived neoantigens and non-classical antigens for anticancer therapies
by: Belen Aparicio, et al.
Published: (2024-12-01) -
Synergistic Integration of HDAC Inhibitors and Individualized Neoantigen Therapy (INT): A Next-Generation Combinatorial Approach for Cancer Immunotherapy
by: Rui Han, et al.
Published: (2025-05-01) -
Identification of neoantigen epitopes in cervical cancer by multi-omics analysis
by: Jing Yuan, et al.
Published: (2025-08-01) -
Rapid and direct discovery of functional tumor specific neoantigens by high resolution mass spectrometry and novel algorithm prediction
by: Huajian Tian, et al.
Published: (2025-06-01) -
Reversing the “cold” tumor microenvironment: the role of neoantigen vaccines in prostate cancer
by: Jiani Wang, et al.
Published: (2025-07-01)